Article ; Online: Recent advances in antiviral drug development towards dengue virus.
2020 Volume 43, Page(s) 9–21
Abstract: Despite the high disease burden of dengue virus, there is no approved antiviral treatment or broadly applicable vaccine to treat or prevent dengue virus infection. In the last decade, many antiviral compounds have been identified but only few have been ... ...
Abstract | Despite the high disease burden of dengue virus, there is no approved antiviral treatment or broadly applicable vaccine to treat or prevent dengue virus infection. In the last decade, many antiviral compounds have been identified but only few have been further evaluated in pre-clinical or clinical trials. This review will give an overview of the direct-acting and host-directed antivirals identified to date. Furthermore, important parameters for further development that is, drug properties including efficacy, specificity and stability, pre-clinical animal testing, and combinational drug therapy will be discussed. |
---|---|
MeSH term(s) | Animals ; Antiviral Agents/pharmacology ; Dengue/drug therapy ; Dengue/virology ; Dengue Virus/drug effects ; Dengue Virus/genetics ; Dengue Virus/physiology ; Drug Development/trends ; Humans |
Chemical Substances | Antiviral Agents |
Language | English |
Publishing date | 2020-08-11 |
Publishing country | Netherlands |
Document type | Journal Article ; Research Support, Non-U.S. Gov't ; Review |
ZDB-ID | 2611378-8 |
ISSN | 1879-6265 ; 1879-6257 |
ISSN (online) | 1879-6265 |
ISSN | 1879-6257 |
DOI | 10.1016/j.coviro.2020.07.009 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.